News Focus
News Focus
Followers 96
Posts 12269
Boards Moderated 0
Alias Born 06/06/2014

Re: hnbadger1 post# 320630

Sunday, 07/11/2021 8:24:33 PM

Sunday, July 11, 2021 8:24:33 PM

Post# of 518776
The article states: "...given the rapid improvement in symptoms it will be important to determine if this effect is actually disease-modifying or simply a symptomatic effect. Blarcamesine was prioritised by our international Linked Clinical Trials committee in 2020, and Cure Parkinson’s is keen to see it evaluated in a larger future phase 3 clinical study."

They must be part of the cabal conspiracy cleverly trying to prevent early approval by delaying our magic bean so they and BP and the shorts and manipulators can make their greedy billions and so we can't win the Nobel in Medicine and provide humanity and our pets with the fountain of youth and thwart our dreams of retiring rich, even though it's really all about the children.

Or, it's a medical foundation that supports continued testing for our promising experimental drug to best determine if and how it's effective.

Must be the conspiracy thingy smile
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News